← Evidence map

ArticleDrug delivery2022

Disitamab vedotin: a novel antibody-drug conjugates for cancer therapy.

Fan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

142 papers cite itlatest 60 shown

2022
…
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35506447